Overview

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to evaluate the efficacy and safety of intravenous HRS9432 in patients with candidemia and/or invasive candidiasis
Phase:
Phase 2
Details
Lead Sponsor:
Fujian Shengdi Pharmaceutical Co., Ltd.
Treatments:
Caspofungin